How to Help Your Patients Find Linzess in Stock: A Provider's Guide

If your patients are calling your office because they can't fill their Linzess prescription, you're not alone. Despite Linzess (linaclotide) not being in a national shortage, access barriers in 2026 are real—and you can play a key role in helping patients navigate them. This guide is designed for gastroenterologists, primary care physicians, and their staff.

Why Patients Can't Fill Linzess: The Root Causes

Before implementing solutions, understanding the barriers helps you triage effectively:

1. Pharmacy doesn't stock it: Small pharmacies may not routinely stock Linzess. The patient needs to find a different pharmacy.
2. Prior authorization pending or denied: Insurance is delaying or blocking coverage.
3. Cost: Patient can't afford the copay or is uninsured and facing $680+ out-of-pocket.
4. Step therapy requirements: Insurance requires documentation of prior treatment failures before approving Linzess.

Step 1: Help Patients Find a Pharmacy With Linzess in Stock

Recommend that patients use medfinder. medfinder is a service that calls pharmacies near the patient to identify which ones have Linzess in stock and can fill the prescription. Results are texted to the patient. This eliminates hours of phone calls for both patients and your office staff.

Alternatively, advise patients to try large chain pharmacies first—CVS, Walgreens, Walmart, Costco, and Rite Aid stock Linzess more reliably than independent pharmacies. Mail-order pharmacies affiliated with patients' insurance plans are another reliable option, particularly for 90-day supplies.

Step 2: Streamline the Prior Authorization Process

Prior authorization is the most common reason for Linzess access delays. Here's how to speed up the process:

• Ensure your documentation includes the specific ICD-10 diagnosis code (IBS-C: K58.0; CIC: K59.04; FC: K59.00), symptom duration, and severity
• Record any prior treatment attempts in the chart: fiber supplements, polyethylene glycol (PEG/MiraLAX), stimulant laxatives, or other osmotic agents
• Use electronic PA tools integrated with your EHR when available (CoverMyMeds, ePA through pharmacy systems)
• Contact AbbVie's HCP support line for PA assistance: the linzesshcp.com portal has formulary lookup and PA support tools
• If the PA is denied, file an appeal with updated clinical documentation; urgent PA processing is available when clinically warranted

Step 3: Connect Patients to Cost Assistance

Have your front desk or care coordinator ready to share these resources:

• Linzess Savings Card (commercially insured patients): $30/month copay, max $2,280/year savings. Text LINZESS to 59257 or call 1-855-859-5614. Not valid for Medicare/Medicaid.
• AbbVie Patient Assistance Foundation (uninsured, income-qualified): Up to 12 months free. Physician signature required on application. Call 1-800-222-6885 or visit abbviepaf.org.
• Medicare Extra Help: Medicare patients with limited income may qualify for the Extra Help program, which can reduce the Linzess copay to as little as $12.65/month for brand-name drugs in 2026.
• GoodRx / SingleCare: Useful for uninsured patients who don't qualify for PAP or while PA is pending. Can reduce price from $736 to ~$252.

Step 4: Know When to Switch Therapies

If access barriers are persistent and the patient is not responding to alternatives, consider a therapeutic switch. Read our Linzess alternatives guide for a detailed comparison. Key clinical considerations:

• If cost is the primary barrier: generic lubiprostone (Amitiza) or generic prucalopride (Motegrity) may provide relief at lower cost
• If the patient has IBS-C and failed GC-C agonists: tenapanor (Ibsrela) provides a mechanistically distinct option
• If the patient has CIC and slow motility is primary: prucalopride (Motegrity) targets GI motility via 5-HT4 receptor agonism

Build a Pharmacy Referral List for Your Practice

Consider maintaining a short list of local chain pharmacies and mail-order pharmacies that reliably stock Linzess. Share this with patients at the point of prescribing. This proactive communication can prevent a gap in therapy and reduce the number of calls your office receives from frustrated patients.

For a more systematic solution, medfinder for providers can be integrated into your patient communication workflow to help patients locate their medication quickly without burdening your staff.